Literature DB >> 12044339

The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia.

Xiao Yan Zhong1, Wolfgang Holzgreve, Sinuhe Hahn.   

Abstract

OBJECTIVE: Elevations in cell free fetal DNA has previously been determined in pregnancies affected by preeclampsia. A recent report has indicated that cell free fetal DNA concentrations are elevated early in pregnancy before disease onset. As we have recently performed a prospective study to examine fetal cell traffic in pregnancies at risk for developing preeclampsia, we now quantify cell free fetal DNA concentrations in these samples.
METHODS: Blood samples were collected in the second trimester of pregnancy from pregnancies at risk for preeclampsia. Cell free fetal DNA amounts were quantified by real-time PCR. These results were then correlated with subsequent pregnancy outcome.
RESULTS: Free fetal DNA levels were significantly higher (median of 422.9 vs. 128.5 copies/mL maternal plasma; p=0.005) in plasma samples from women who developed preeclampsia ( n=10) when compared to those who had unremarkable pregnancies ( n=40).
CONCLUSIONS: Our data independently confirm the finding that maternal plasma cell free fetal DNA levels are elevated early in pregnancies, which later develop preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044339     DOI: 10.1081/PRG-120002911

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  29 in total

1.  MALDI-TOF MS in Prenatal Genomics.

Authors:  Xiao Yan Zhong; Wolfgang Holzgreve
Journal:  Transfus Med Hemother       Date:  2009-06-25       Impact factor: 3.747

2.  Cell-Free Total and Fetal DNA in First Trimester Maternal Serum and Subsequent Development of Preeclampsia.

Authors:  Robert M Silver; Leslie Myatt; John C Hauth; Kenneth J Leveno; Alan M Peaceman; Susan M Ramin; Philip Samuels; George Saade; Yoram Sorokin; Rebecca G Clifton; Uma M Reddy
Journal:  Am J Perinatol       Date:  2016-07-11       Impact factor: 1.862

3.  Membrane protected apoptotic trophoblast microparticles contain nucleic acids: relevance to preeclampsia.

Authors:  Aaron F Orozco; Carolina J Jorgez; Cassandra Horne; Deborah A Marquez-Do; Matthew R Chapman; John R Rodgers; Farideh Z Bischoff; Dorothy E Lewis
Journal:  Am J Pathol       Date:  2008-10-30       Impact factor: 4.307

Review 4.  Cell-Free Fetal DNA for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-Analysis.

Authors:  Elena Contro; Dalila Bernabini; Antonio Farina
Journal:  Mol Diagn Ther       Date:  2017-04       Impact factor: 4.074

Review 5.  Non-invasive Prenatal Testing Using Fetal DNA.

Authors:  Giulia Breveglieri; Elisabetta D'Aversa; Alessia Finotti; Monica Borgatti
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

6.  Levosimendan reduces plasma cell-free DNA levels in patients with ischemic cardiomyopathy.

Authors:  Apostolos Zaravinos; Spiros Tzoras; Stavros Apostolakis; Kyriakos Lazaridis; Demetrios A Spandidos
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

Review 7.  Placental apoptosis in health and disease.

Authors:  Andrew N Sharp; Alexander E P Heazell; Ian P Crocker; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2010-09       Impact factor: 3.886

8.  Biochemical markers for prediction of preclampsia: review of the literature.

Authors:  Santo Monte
Journal:  J Prenat Med       Date:  2011-07

9.  Placental release of distinct DNA-associated micro-particles into maternal circulation: reflective of gestation time and preeclampsia.

Authors:  A F Orozco; C J Jorgez; W D Ramos-Perez; E J Popek; X Yu; C A Kozinetz; F Z Bischoff; D E Lewis
Journal:  Placenta       Date:  2009-08-18       Impact factor: 3.481

Review 10.  Potential markers of preeclampsia--a review.

Authors:  Simon Grill; Corinne Rusterholz; Rosanna Zanetti-Dällenbach; Sevgi Tercanli; Wolfgang Holzgreve; Sinuhe Hahn; Olav Lapaire
Journal:  Reprod Biol Endocrinol       Date:  2009-07-14       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.